Provide blood for studies comparing HIV groups
Part of Infections clinical trials.
This study collects blood to help researchers run multiple projects, including comparing people who are HIV-negative with people who have HIV. It may help advance knowledge that could improve future testing or treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are either HIV-negative or have HIV-1, and your situation is similar to the study’s comparison group
- If you have HIV, you must be new to HIV medications or have been on/off them in a stable way for at least 6 months
- You must have veins that are suitable for drawing blood
- Your blood counts must be safe enough: hemoglobin 9 g/dL or higher, and hematocrit 27% or higher
- You must be able to understand the study and sign an informed consent form
- You should not currently be in active cancer treatment, and not have had chemotherapy or similar immune-suppressing care recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special blood-filtering procedure (leukapheresis) along with blood tests to better understand how HIV affects the body. It may help researchers learn more about HIV “pathogenesis,” which means what drives disease in different people.
This study uses a small tissue sample from an often-accessible lymph node to learn how HIV affects the body. It may help researchers understand why some people control HIV better than others.
This research study collects blood cells from people recently diagnosed with HIV who haven't started HIV medicines yet. Researchers use these samples to understand how HIV affects the immune system and develop better treatments.
This research study collects blood cells from adults with HIV and their family members to understand why some people's immune systems control HIV better than others. Researchers will use your cells to study HIV immunity and develop better treatments.
This study measures how much HIV is in your blood and lymph node tissue. If you qualify, you would also allow blood and other tests (including genetic and hepatitis screening), which may help researchers better understand how HIV affects the body.
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.